April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Generation and characterization of retinal ganglion cells from glaucoma patient iPSCs
Author Affiliations & Notes
  • Yvonne Ou
    Ophthalmology, University of California, San Francisco, San Francisco, CA
  • Karen L Chu
    Ophthalmology, University of California, San Francisco, San Francisco, CA
  • Erik M Ullian
    Ophthalmology, University of California, San Francisco, San Francisco, CA
    Physiology, University of California, San Francisco, San Francisco, CA
  • Footnotes
    Commercial Relationships Yvonne Ou, None; Karen Chu, None; Erik Ullian, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1361. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yvonne Ou, Karen L Chu, Erik M Ullian; Generation and characterization of retinal ganglion cells from glaucoma patient iPSCs. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1361.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Glaucoma, the leading cause of irreversible blindness worldwide, is a degenerative optic neuropathy characterized by gradual loss of peripheral vision and eventual blindness. The underlying cause of visual dysfunction is the progressive loss of retinal ganglion cells (RGCs) and their axons. Recently, retinal ganglion cell-like cells have been derived from human embryonic stem cells and human induced pluripotent stem cells (hiPSCs). However, the proportion of cells in these cultures that are iPSC-derived RGCs (iPSC-RGCs) is typically low. Here we describe a modified protocol based on existing methods to increase the proportion of iPSC-RGCs derived from glaucoma patients in order to establish a human glaucoma cell culture model.

Methods: Skin biopsies were obtained from glaucoma patients seen at the UCSF Department of Ophthalmology’s Glaucoma Service. Multiple hiPSC lines were established using nonintegrating episomal reprogramming vectors consisting of OCT 3/4, c-Myc, KLF4, and SOX2. The glaucoma patient-derived hiPSCs were differentiated into RGCs in the presence of various BMP and Wnt inhibitors, as well as IGF-1 and Sonic hedgehog (Shh). The retinal progenitor cells and differentiated neurons produced were then assayed using RT-PCR and immunofluorescence microscopy.

Results: Glaucoma patient-derived hiPSC lines were established and then differentiated into retinal progenitors as assayed by expression of eye-field transcription factors. The addition of DAPT, a Notch signaling pathway inhibitor, increased the proportion of cells expressing neuronal and RGC-specific markers. The inclusion of Shh increased the proportion of Brn3a-expressing cells in a concentration dependent manner (25.4% at 100 ng/ml vs. 11.4% at 10 ng/ml; p<0.05). These glaucoma patient-derived iPSC-RGCs were also capable of forming anatomic synapses by synaptic marker expression.

Conclusions: We have modified existing protocols to enhance the differentiation of RGCs from glaucoma patient-derived hiPSCs, providing an abundant source of cells for the establishment of an in vitro cell culture model of human glaucoma.

Keywords: 721 stem cells • 531 ganglion cells • 694 retinal culture  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×